Gatlan review

Gatlan names NAD⁺ injections on its homepage and a rapamycin-and-NAD⁺ longevity category from $200 a month. That price does not isolate the NAD⁺ drug, dose or supply. It names a medical group and advisor, and its terms identify Immortal Male Inc. Its state list is internally inconsistent: 47 states plus DC are enumerated, while a 44-state counter remains. Confirm both product eligibility and the actual first charge before joining.

Gatlan is a telehealth platform whose terms name Immortal Male Inc. The site advertises TRT, weight care, hair treatment and a longevity category explicitly pairing rapamycin with NAD⁺. Its homepage separately lists NAD⁺ injections. The experience page names Elevis Medical Group under David Lawrence for care; the site names Robert Lufkin as Chief Medical Advisor. Those are the company's role and credential statements, not an independent credential check. Consultations are advertised as free. A linked LegitScript image appears on the homepage, without independent certification verification.

A free consultation precedes provider review, with labs determined by the clinician and ongoing contact advertised. The terms say users must be at least eighteen or legally emancipated, describe no insurance billing, and generally deny refunds except at the company's discretion. The homepage lists 47 states plus DC but keeps a 44-state counter, so confirm eligibility for your location and selected treatment. The dispensing pharmacy and any 503 designation are unnamed. Privacy material also names ClicktoFill and WellSync while the terms name Immortal Male; their roles are not fully explained.

The longevity category pairing rapamycin and NAD⁺ starts at $200 a month. That is a category headline, not a standalone NAD⁺ price or a confirmed first debit. TRT and weight care start at $125, hair at $49, glutathione at $39 and pre-workout at $79; none sets the NAD⁺ price. Ask what medication, dose, route, supply, labs and shipping the selected longevity quote covers and how renewal and cancellation work.

Compounded where compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Gatlan names no compounding pharmacy, gives no 503A or 503B designation, and publishes no compounded-medication disclaimer of its own, so the statement above is ours rather than the platform's — compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, rapamycin and NAD⁺, two drugs often sold together under a longevity banner, should not be evaluated together. Rapamycin has a substantial mechanistic and animal-model literature and an immunosuppressive side-effect profile that requires real clinical oversight; it is not approved for longevity use in humans. Injected NAD⁺ has no controlled human outcome trials at all — the single human intravenous study was a pharmacokinetic pilot that found infused NAD⁺ clears from plasma quickly — and the NAD⁺ forms with human data are the oral precursors NR and NMN, which reliably raise blood NAD⁺, a raised biomarker rather than a demonstrated benefit. Glutathione, which Gatlan names, has essentially no controlled human outcome evidence. If you also take up the testosterone line, it carries real monitoring requirements and suppresses fertility. Individual results vary.